Andrew L. Frelinger

11.8k citations

170 papers · 9.0k indexed · 1 hit paper · h-index 50

Impact in

Internal Medicine top 0.2%
- Venous Thromboembolism Diagnosis and Management
Hematology top 0.2%
- Platelet Disorders and Treatments

Papers in

Hematology 88
- Platelet Disorders and Treatments 77
- Blood groups and transfusion 14
Internal Medicine 26
- Venous Thromboembolism Diagnosis and Management 26

Co-authors: Alan D. Michelson Mark H. Ginsberg Mark I. Furman Marc R. Barnard Edward F. Plow Joseph C. Loftus Matthew D. Linden Marsha L. Fox
Journals: Blood (27 papers)Journal of Thrombosis and Haemostasis (19 papers)Platelets (11 papers)Circulation (9 papers)Thrombosis and Haemostasis (9 papers)
Partner nations: United States United Kingdom Austria

In The Last Decade

Andrew L. Frelinger

166 papers receiving 8.7k citations

Hit Papers

align trajectories log scale

Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention 2007 · 623 citations

Peers

Countries citing papers authored by Andrew L. Frelinger

Since Specialization

Citations

This map shows the geographic impact of Andrew L. Frelinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew L. Frelinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew L. Frelinger more than expected).

Fields of papers citing papers by Andrew L. Frelinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew L. Frelinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew L. Frelinger. The network helps show where Andrew L. Frelinger may publish in the future.

Co-authors

The 25 scholars most cited alongside Andrew L. Frelinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew L. Frelinger Line = papers co-authored together Andrew L. Frelinger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Clinical and research methods for analysis and study of platelet populations Blood ·Thomas Thiele, Johan W. M. Heemskerk, Andrew L. Frelinger	2025	0
2	Flow Cytometry and Platelets Clinics in Laboratory Medicine ·Andrew L. Frelinger	2024	2
3	Dysregulation of platelet serotonin, 14–3–3, and GPIX in sudden infant death syndrome Scientific Reports ·Andrew L. Frelinger, Robin L. Haynes, Richard D. Goldstein, Michelle A. Berny‐Lang, Anja J. Gerrits, Molly Riehs, Elisabeth A. Haas, Brankica Paunovic, Othon J. Mena, Steven C. Campman, Ginger L. Milne, Lynn A. Sleeper, Hannah C. Kinney, Alan D. Michelson	2024	1
4	Expert opinion on the use of platelet secretion assay for the diagnosis of inherited platelet function disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology Journal of Thrombosis and Haemostasis ·Diego Mezzano, Paul Harrison, Andrew L. Frelinger, Andrew Mumford, Patrizia Noris, Marie Lordkipanidzé, Paolo Gresele	2022	14
5	Consensus recommendations on flow cytometry for the assessment of inherited and acquired disorders of platelet number and function: Communication from the ISTH SSC Subcommittee on Platelet Physiology Journal of Thrombosis and Haemostasis ·Andrew L. Frelinger, José Rivera, David Connor, Kathleen Freson, Andreas Greinacher, Paul Harrison, Shinji Kunishima, Marie Lordkipanidzé, Alan D. Michelson, Sofia Ramström, Paolo Gresele	2021	35
6	Mass Cytometry of Platelets: Simultaneous Functional and Phenotypic Analysis of Multiple Surface Markers in Healthy Subjects and Patients with Inherited Platelet Disorders Reveals Novel Platelet Sub-Populations Blood ·Thomas A. Blair, Alan D. Michelson, Andrew L. Frelinger	2017	1
7	Platelet Function in Thrombocytopenic Patients with Chronic Liver Disease Blood ·Elena Smolensky Koganov, Sabrina L. Carmichael, Emma E Forde, Andrew L. Frelinger, Alan D. Michelson	2017	4
8	Avatrombopag, a Novel Thrombopoietin Receptor Agonist, Increases Platelet Counts without Increasing Platelet Activation in Patients with Thrombocytopenia Due to Chronic Liver Disease Blood ·Andrew L. Frelinger, Elena Smolensky Koganov, Emma E Forde, Sabrina L. Carmichael, Alan D. Michelson	2017	4
9	Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus Journal of the American College of Cardiology ·Deepak L. Bhatt, Tilo Großer, Jing-fei Dong, Douglas Logan, Walter Jeske, Dominick J. Angiolillo, Andrew L. Frelinger, Lanyu Lei, Juan Liang, Jason E. Moore, Byron Cryer, Upendra Marathi	2017	106
10	Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syndrome/X-linked thrombocytopenia Blood ·Anja J. Gerrits, Emily Leven, Andrew L. Frelinger, Sophie L. Brigstocke, Michelle A. Berny‐Lang, W. Beau Mitchell, Shoshana Revel‐Vilk, Hannah Tamary, Sabrina L. Carmichael, Marc R. Barnard, Alan D. Michelson, James B. Bussel	2015	58
11	Variability of Individual Platelet Reactivity Over Time in Patients Treated With Clopidogrel Journal of the American College of Cardiology ·Willibald Hochholzer, Christian T. Ruff, R. A. Mesa, John F. Mattimore, John F. Cyr, Lanyu Lei, Andrew L. Frelinger, Alan D. Michelson, David D. Berg, Dominick J. Angiolillo, Michelle L. O’Donoghue, Marc S. Sabatine, Jessica L. Mega	2014	61
12	A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease Journal of Hematology & Oncology ·Ted Wun, Denis Soulières, Andrew L. Frelinger, Lakshmanan Krishnamurti, Enrico M. Novelli, Abdullah Kutlar, Kenneth I. Ataga, Charles Knupp, Lillian E.C. McMahon, John J. Strouse, Chunmei Zhou, Lori E. Heath, Chuke Nwachuku, Joseph A. Jakubowski, Jeffrey S. Riesmeyer, Kenneth J. Winters	2013	54
13	The Human Endogenous Circadian System Causes Greatest Platelet Activation during the Biological Morning Independent of Behaviors PLoS ONE ·Frank A. J. L. Scheer, Alan D. Michelson, Andrew L. Frelinger, Heather Evoniuk, Erin E. Kelly, Mary C. McCarthy, Laurén A. Doamekpor, Marc R. Barnard, Steven A. Shea	2011	157
14	Effects of in vitro adult platelet transfusions on neonatal hemostasis Journal of Thrombosis and Haemostasis ·Francisca Ferrer‐Marín, Chaitanya Chavda, Michael Lampa, Alan D. Michelson, Andrew L. Frelinger, Martha Sola‐Visner	2011	54
15	Decrease in Poor Responders on Switching From Clopidogrel to Prasugrel: Results From the SWitching Anti Platelet (SWAP) Study Circulation ·Jorge F. Saucedo, Dominick J. Angiolillo, Roger DeRaad, Andrew L. Frelinger, Paul A. Gurbel, Timothy M. Costigan, Joseph A. Jakubowski, Clement K. Ojeh, Mark B. Effron	2009	0
16	Comparison of Prasugel With Clopidogrel on Platelet Function in Coronary Artery Disease Patients With Type 2 Diabetes Mellitus - Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3) Circulation ·Dominick J. Angiolillo, Juan J. Badimon, Jorge F. Saucedo, Andrew L. Frelinger, Alan D. Michelson, Joseph A. Jakubowski, Baojin Zhu, Clement K. Ojeh, Brian Baker, Mark B. Effron	2009	2
17	Abstract 3994: Pharmacodynamic Assessment of Platelet Inhibition by Prasugrel versus Clopidogrel in the TRITON-TIMI 38 Trial Circulation ·Andrew L. Frelinger, Alan D. Michelson, Eugene Braunwald, William E. Downey, Dominick J. Angiolillo, Nicholas Xenopoulos, Joseph A. Jakubowski, Youfu Li, Sabina A. Murphy, Jie Qin, Carolyn H. McCabe, Elliott M. Antman, Stephen D. Wiviott	2008	2
18	The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirin Journal of Thrombosis and Haemostasis ·Andrew L. Frelinger, J.A. Jakubowski, Y. Li, M.R. BARNARD, Marsha L. Fox, Matthew D. Linden, Atsuhiro Sugidachi, Kenneth J. Winters, M.I. Furman, A D Michelson	2007	5
19	Indices of platelet activation and the stability of coronary artery disease Journal of Thrombosis and Haemostasis ·Matthew D. Linden, M.I. Furman, Andrew L. Frelinger, Marsha L. Fox, M.R. BARNARD, Y. LI, Karin Przyklenk, Alan D. Michelson	2007	94
20	Residual Arachidonic Acid–Induced Platelet Activation via an Adenosine Diphosphate–Dependent but Cyclooxygenase-1– and Cyclooxygenase-2–Independent Pathway Circulation ·Andrew L. Frelinger, Mark I. Furman, Matthew D. Linden, Youfu Li, Marsha L. Fox, Marc R. Barnard, Alan D. Michelson	2006	227

About Andrew L. Frelinger

Andrew L. Frelinger is a scholar working on Hematology, Internal Medicine, Cardiology and Cardiovascular Medicine, Immunology and Allergy and Genetics, having authored 170 papers that have together received 9.0k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (77 papers), Antiplatelet Therapy and Cardiovascular Diseases (69 papers), Venous Thromboembolism Diagnosis and Management (26 papers), Acute Myocardial Infarction Research (21 papers), Cell Adhesion Molecules Research (17 papers), Blood properties and coagulation (14 papers), Blood groups and transfusion (14 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers). The work is most often cited by research in Internal Medicine (1.3k citations), Hematology (3.2k citations), Immunology and Allergy (1.6k citations), Cardiology and Cardiovascular Medicine (4.0k citations) and Surgery (2.1k citations). Andrew L. Frelinger has collaborated with scholars based in United States, United Kingdom and Austria. Frequent co-authors include Alan D. Michelson, Mark H. Ginsberg, Mark I. Furman, Marc R. Barnard, Edward F. Plow, Joseph C. Loftus, Matthew D. Linden, Marsha L. Fox, Lori A. Krueger and Timothy E. O’Toole. Their work appears in journals such as Blood, Journal of Thrombosis and Haemostasis, Platelets, Circulation and Thrombosis and Haemostasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact